Biological Information Repair in diabetes: a translational model for reprogramming cellular signalling in all types of diabetes mellitus
Background. Given the current understanding of diabetes mellitus as a multifactorial systemic disease with profound disturbances in cellular signalling, metabolic regulation, and intercellular communication, novel translational approaches that can influence glycaemic control and biological informational disorganization in target tissues are needed. The purpose of this study was to evaluate the Biological Information Repair concept as a method of restoring signalling and metabolic homeostasis in patients with type 1 and type 2 diabetes mellitus. Materials and methods. A single-centre, prospective, open-label interventional study with duration of 12 months included 110 patients aged 18–70 years (37 with type 1 diabetes and 73 with type 2 diabetes). Biological Information Repair included nutritional modification of each patient’s diet, adjustment of their pharmacotherapy, and correction of other cardiometabolic risk factors. Results. Over 12 months, glycated haemoglobin levels dropped from an initial average of 8.9 to 7.4 % (p < 0.001). Fasting plasma glucose levels declined from 9.6 ± 2.1 to 7.4 ± 1.5 mmol/L (p < 0.001). In patients with preserved endogenous insulin secretion, the Homeostatic Model Assessment of Insulin Resistance reduced from an initial average of 4.8 ± 1.6 to 3.2 ± 1.1 (p < 0.001). Additionally, body mass index values decreased from an initial average of 30.8 ± 4.9 to 28.9 ± 4.4 kg/m2 (p = 0.004). Systolic and diastolic blood pressure values also dropped by 9 and 5 mmHg, respectively (p = 0.01 and p = 0.03). Furthermore, levels of albumin in the urine decreased significantly (p = 0.04), while glomerular filtration rate remained stable. Conclusions. The most pronounced metabolic and anti-inflammatory effects were observed in type 2 diabetes. The practical significance of this study lies in the possibility of employing the Biological Information Repair approach to manage type 1 and type 2 diabetes mellitus in a way that is individualized to each patient.
Authors
- I. Siemionkowicz (ORCID: https://orcid.org/0009-0006-1162-9092)
Publication Details
- Journal
- INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
- Published
- 2026-11-14
- DOI
- https://doi.org/10.22141/2224-0721.22.7.2026.1778
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00